Professor Thomas Kay

Professor Thomas Kay


Director, St. Vincent’s Institute of Medical Research
St. Vincent’s Institute of Medical Research
Elected in 2016
Citation on election

Tom Kay is Director of St. Vincent’s Institute and President of the Immunology of Diabetes Society. He is Chief Investigator on an NHMRC Program Grant, “Pathogenesis-based Treatment of Type 1 Diabetes”. As an endocrinologist and clinical immunologist he leads the Victorian node of the Australian Islet Transplant Consortium. Contributions include the role of CD8+ T cells and cytokines in the death of pancreatic beta cells and characterization of T cells in type 1 diabetes. These are relevant to developing new treatments for diabetes that could replace the need for insulin injections by restoring endogenous insulin and by correction of autoimmunity.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.